Kōsai sonshō wa zenbōsui saitokain nōdo jōshō to kanrensuru by アケタ, ナオヒコ et al.
Special Issue
Iris Damage Is Associated With Elevated Cytokine Levels in
Aqueous Humor
Naohiko Aketa, Takefumi Yamaguchi, Terumasa Suzuki, Kazunari Higa, Yukari Yagi-Yaguchi,
Yoshiyuki Satake, Kazuo Tsubota, and Jun Shimazaki
Department of Ophthalmology, Ichikawa General Hospital, Tokyo Dental College, Chiba, Japan
Correspondence: Takefumi Yamagu-
chi, Department of Ophthalmology,
Ichikawa General Hospital, Tokyo
Dental College, 5-11-13, Sugano,
Ichikawa, Chiba, 272-8513, Japan;
tym.i.eye.i@gmail.com.
Submitted: January 3, 2017
Accepted: March 14, 2017
Citation: Aketa N, Yamaguchi T, Suzu-
ki T, et al. Iris damage is associated
with elevated cytokine levels in aque-
ous humor. Invest Ophthalmol Vis Sci.
2017;58:BIO42–BIO51. DOI:10.1167/
iovs.17-21421
PURPOSE. To evaluate the association between iris damage and cytokine levels in the aqueous
humor (AqH).
METHODS. A total of 201 AqH samples from 201 consecutive patients (mean age 73.7 6 10.6)
were collected at the beginning of corneal transplantation or cataract surgery. Iris damage of
each case was assessed from preoperative slit-lamp findings based on its severity. The subjects
were classified into three groups: eyes without iris damage (126 eyes), eyes with mild iris
damage (51 eyes), and eyes with severe iris damage (24 eyes). The levels of cytokines (IL-1a,
IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-17a, interferon gamma-induced protein [IP]-10,
monocyte chemotactic protein [MCP]-1, IFN-a, IFN-c, macrophage inflammatory protein
[MIP]-1a, MIP-1b, P-selectin, E-selectin, soluble intercellular adhesion molecule [sICAM]-1,
TNF-a, and granulocyte-macrophage colony-stimulating factor [GM-CSF]) in AqH were
measured by multiplex beads immunoassay.
RESULTS. The levels of aqueous protein, IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-17A, MCP-1,
TNF-a, E-selectin, P-selectin, and sICAM-1 in eyes with mild and severe iris damage were
higher than in those without iris damage (P < 0.033). Multivariate analyses of clinical
factors revealed that iris damage was associated with the history of complicated glaucoma,
and the number of previous intraocular surgeries. The levels of AqH IL-6, IL-8, IL-13, MIP-
1a, TNF-a, and sICAM-1 were significantly elevated in eyes with mild and severe iris damage
in phakic eyes, and the levels of AqH IL-8 and sICAM-1 were significantly elevated in eyes
with severe iris damage in pseudophakic eyes, compared with the eyes without iris damage
(P < 0.045).
CONCLUSIONS. Iris damage was associated with the elevation in the levels of aqueous protein
and cytokines.
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Aqueous humor (AqH) maintains a normal homeostaticenvironment in the eye and is essential for the proper
functioning of tissues in its anterior chamber.1 Immunomod-
ulatory properties of AqH protect the delicate internal
structures of the visual axis from the blinding conditions of
innate and adaptive immune inflammations.2–4 Aqueous
humor contains a variety of important immunomodulatory
factors, that inhibit T cells and complement activation in
AqH.5–8 The concentrations of protein and ion content in AqH
are different from those in plasma; some of the proteins and
ions are secreted from tissues in the anterior segment.1 Several
laboratory studies have demonstrated that AqH as well as
cultured explants of whole iris and ciliary body (I/CB), or
single-cell suspensions derived from these tissue-secreted
supernatants, suppress T cell activation in vitro.9,10 The
changes in AqH proteome can correlate with the prognosis of
eye diseases.1,11 However, in clinical setting, the association
between I/CB factors and anti-inflammatory effects has been
poorly understood.
Graft rejection and chronic loss of endothelial cell density
(ECD) are the major concerns in improving the prognosis of
corneal transplantation. Recently, using Cox hazard analysis, we
identified that preexistence of severe iris damage was one of
the clinical factors for graft failure and rapid ECD loss after
Descemet’s stripping automated endothelial keratoplasty
(DSAEK)12; in eyes with severe iris damage, ECD decreases
rapidly, leading to graft failure. Moreover, we recently showed
the elevation of inflammatory cytokine levels in AqH in eyes
with bullous keratopathy and reduced ECD.13 A question that
arises is why ECD decreases in eyes with severe iris damage.
Anatomically, the AqH is present between the corneal
endothelium and the iris, and it has been reported that
inflammatory cytokines in AqH are elevated during various
pathological processes.14–16 In a previous study,17 a combina-
tion of proinflammatory cytokines were observed to synergis-
tically induce the apoptosis of corneal endothelial cells in vitro.
In addition, ECDs are lower in eyes with a history of uveitis, and
are correlated with flare in the anterior chamber,18 suggesting
that inflammatory factors in AqH directly influence ECD. Thus,
we hypothesized that the iris damage might be associated with
increased cytokine levels in AqH. In the present study, we
examined the association between the severity of iris damage
and elevated cytokine levels in AqH. Moreover, we evaluated
the clinical factors that predispose iris to damage, and analyzed
their correlation with the levels of inflammatory cytokines in
AqH.
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METHODS
This prospective consecutive study was performed in accor-
dance with the Declaration of Helsinki, and approved by the
Institutional Ethics Review Board of Tokyo Dental College,
Ichikawa General Hospital (I-15-42). Written informed consent
was obtained from all the participants.
Patients
A total of 201 consecutive patients who underwent corneal
transplantation and cataract surgery at Tokyo Dental College in
the period from October, 2015 to September, 2016 were
included. The demographics of the participants are shown in
Table 1. The diseases for which surgeries were performed
included bullous keratopathy (72 eyes), cataract (61 eyes),
corneal scar (28 eyes), Fuchs’ endothelial corneal dystrophy
(FECD; 19 eyes), hereditary epithelial/stromal dystrophies (11
eyes; lattice corneal dystrophy, 5 eyes; macular corneal
dystrophy, 3 eyes; granular corneal dystrophy, 3 eyes), and
keratoconus (10 eyes). We did not perform corneal transplan-
tation or cataract surgery in eyes with active inflammation of
the cornea or anterior chamber, and such eyes were not
included in the study. We confirmed that the anterior chamber
did not contain cells, ciliary injections, or keratoprecipitates
using slit-lamp microscopy before surgery. As for flare in the
anterior chamber, we measured aqueous protein levels directly,
because it was often difficult to assess the flare accurately
using slit-lamp microscopy in the eyes with corneal opacity. We
excluded 18 eyes with ocular comorbidities (8 eyes with a
history of exfoliation syndrome, 3 eyes with chemical burn, 2
eyes with ocular cicatricial pemphigoid, 1 eye with aniridia, 1
eye with endotheliitis, 1 eye with Stevens-Johnson syndrome, 1
with exposure keratitis, and 1 eye with iritis), because previous
studies showed that aqueous cytokine levels are elevated in
eyes with exfoliation syndrome due to breakdown of the
blood–aqueous barrier (BAB),19 and that tear cytokine levels
are elevated in inflammatory ocular surface diseases,20,21
which can affect aqueous cytokine levels due to breakdown
of the corneal epithelial barrier.22 In the eyes with cataract and
bullous keratopathy, when we perform two-step surgery, we
always perform cataract surgery first, followed by DSAEK, with
an interval of more than 3 months. In the eyes with cataract
after penetrating keratoplasty (PKP), we make it a rule to wait
for an interval of more than 6 months after PKP to perform the
cataract surgery.
AqH Samples
Aqueous humor was obtained under sterile conditions at the
beginning of surgery after retrobulbar anesthesia in corneal
transplantation or topical anesthesia in cataract surgery. First,
paracentesis was placed at the clear cornea. The AqH samples
(70–300 lL) were obtained using a 27-G needle, taking care not
to touch the iris, lens, or corneal endothelium. The samples
were centrifuged at 3000g for 5 minutes. The soluble fractions
were collected and stored at80 8C until cytokine levels were
measured.
Measurement of Protein Concentration
The concentrations of protein in the AqH samples were
determined using the DC protein assay kit (Bio-Rad, Hercules,
CA, USA). The reactions were based on the Lowry assay, and
were performed according to the manufacturer’s instructions.
In brief, BSA in the concentration range of 0.23 to 1.37 mg/mL
was used as a standard. Samples (5 lL) of BSA and AqH were
added to 96-well microplates; this was followed by immediate
addition of a mixture containing 25 lL of reagent AþS and 200
lL of reagent C. After 15-minutes incubation at room
temperature in the dark, the microplates were read at 690
and 405 nm using a microplate reader (Model550; Bio-Rad).
The concentrations were calculated by the subtraction method
using a microplate manager system (Bio-Rad).
Measurement of Cytokine Levels
The levels of cytokines (IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-
12p70, IL-13, IL-17A, IFN-a, IFN-c, monocyte chemotactic
protein [MCP]-1, TNF-a, E-selectin, P-selectin, soluble intercel-
lular adhesion molecule [sICAM]-1, granulocyte-macrophage
colony-stimulating factor [GM-CSF], macrophage inflammatory
protein [MIP]-1a, MIP-1b, and interferon gamma-induced
protein [IP]-10) in the AqH samples were measured using
Luminex (ProcaPlex kit; Luminex, San Antonio, TX, USA)
beads-based multiplex immunoassay according to previous
reports.13,23 Briefly, 50 lL of AqH samples were incubated with
antibody-coated capture beads in an incubation buffer at room
temperature. After 2-hours incubation, the beads were washed
thrice using washing buffer and phycoerythrin-labeled strepta-
vidin was added and allowed to bind with in the dark at room
temperature for 30 minutes. After three washes with the
washing buffer, 150 lL of the reading buffer was added to the
plates, and the assays were performed using Luminex 200
system.
Definition of the Severity of Iris Damage
Iris damage was defined as iris depigmentation, laser iridotomy,
or iris defect due to intraocular surgeries. The severity grade of
iris damage for each case was determined based on its severity
from slit-lamp findings. Briefly, healthy eyes are regarded as
‘‘no iris damage’’ (Fig. 1A), eyes with ‘‘mild iris damage’’ are
TABLE 1. Demographics of the Subjects
Clinical
Factors Total
Iris Damage
No Mild Severe
Number of
subjects
201 126 51 24
Age 73.7 6 10.6 73.6 6 10.5 75.3 6 10.0 70.8 6 11.7
Sex (male/
female)
80/121 52/74 17/34 11/13
FIGURE 1. Representative cases with iris damage. (A) No iris damage
with a healthy normal iris. (B) Mild iris damage limited to one quadrant.
(C) Mild iris damage limited to two quadrants. (D) After laser iridotomy.
(E) Severe iris damage in three quadrants. (F) Devastating severe iris
damage and atrophy in whole iris.
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defined as iris damage limited to only one (Fig. 1B) to two
quadrants (Fig. 1C), or with laser iridotomy (Fig. 1D), and eyes
with ‘‘severe iris damage’’ are defined as iris damage from three
(Fig. 1E) to four quadrants (Fig. 1F). The causes for iris damage
in the samples used in the current study, included laser
iridotomy (LI; 29 eyes), previous corneal transplantation (22
eyes), complicated cataract surgery (14 eyes), complicated
vitreoretinal surgery (5 eyes), glaucoma surgery (trabeculecto-
my in 8 eyes, goniosynechialysis in 3 eyes and trabeculotomy in
3 eyes), and trauma (5 eyes).
Data Analysis
To identify clinical parameters associated with iris damage, we
selected the following variables, based on the previous studies
and on our knowledge of iris damage: the presence of
intraocular lens (IOL), a history of corneal transplantation,
complicated glaucoma, diabetes mellitus (DM), axial length,
patient age, and number of previous intraocular surgeries.
Complicated glaucoma was defined as glaucoma with a history
of single or multiple glaucoma surgeries or secondary
glaucoma after complicated intraocular surgeries. Clinical
factors, such as a history of IOL, corneal transplantation,
complicated glaucoma, and DM, were dichotomized for
univariate and multivariate analyses. To assess the association
between the clinical factors and iris damage, univariate
analyses were conducted for each variable using Spearman’s
rank correlations. Multiple linear regression analysis was
conducted using stepwise analysis (Model 1) and backward
elimination analysis (Model 2).
Statistical Analysis
Stata statistical software for Windows, version 14.1 (StataCorp
LP, College Station, TX, USA) was used for all the statistical
analyses, and a P value less than 0.05 was considered
statistically significant. The data are expressed as averages
with SE and median for cytokine levels. The Shapiro-Wilk test
was used to assess whether the data showed a normal
distribution. The Mann-Whitney U-test was used to compare
cytokine levels between each iris damage subgroup.
RESULTS
Aqueous Protein Levels in Eyes With and Without
Iris Damage
The aqueous protein levels in eyes without iris damage were
0.51 6 0.46 mg/mL, which significantly increased to 098 6
0.14 mg/mL in eyes with mild iris damage (P ¼ 0.0033) and
1.70 6 0.29 mg/mL in eyes with severe iris damage (P <
0.0001). The aqueous protein level in eyes with severe iris
damage was significantly higher than in eyes with mild iris
damage (Fig. 2, P ¼ 0.016).
Increased Aqueous Cytokine Levels in Eyes With
Iris Damage
The mean cytokine levels in AqH, in terms of iris damage
severity in all the subjects are shown in Table 2. The levels of
IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-17A, MCP-1, TNF-a, E-
selectin, P-selectin, and sICAM-1 in eyes with mild and severe
iris damage were higher than those without iris damage (P <
0.033). The levels of IL-13, MIP-1a, IFN-a and IFN-c in eyes with
mild iris damage were higher than those without iris damage (P
< 0.0036), and IP-10 in eyes with severe iris damage was
higher than that of no iris damage (P ¼ 0.0013). None of the
cytokines in eyes with severe iris damage was lower than that
in eyes without iris damage (P > 0.05), and only IP-10 was
lower in eyes with mild iris damage, compared with that in
eyes without iris damage (P < 0.05). Interferon-a was higher in
eyes with mild iris damage than in eyes with severe iris
damage. There were no other significant differences in the
cytokine levels between eyes with mild and severe iris damage.
Associations Between Clinical Factors and the
Severity of Iris Damage
Table 3 shows the univariate and multivariate regression
analyses of the association between iris damage severity and
clinical factors. Univariate correlation analysis showed iris
damage severity was correlated with the number of previous
intraocular surgeries (q¼ 0.754, P¼ 0.0001), presence of IOL
(q¼ 0.516, P¼ 0.0001), complicated glaucoma (q¼ 0.491, P¼
0.0001), history of corneal transplantation (q ¼ 0.371, P ¼
0.0001), and axial length (q ¼ 0.170, P ¼ 0.018). Multiple
regression analyses showed that iris damage severity had
significant correlations with the number of previous intraoc-
ular surgeries (b ¼ 0.336, P ¼ 0.0001) and history of
complicated glaucoma (b ¼ 0.355, P ¼ 0.013).
Aqueous Cytokine Levels Stratified With the
Severity of Iris Damage in Phakic and
Pseudophakic Eyes
Having demonstrated that the levels of aqueous protein and
cytokines were increased in eyes with iris damage, we assessed
the levels of aqueous protein and cytokines by dividing the
samples into two categories—phakic and pseudophakic
eyes—because previous report has shown that specific
cytokine levels alter after the cataract surgery.15 In phakic
eyes (Table 4, total 142 eyes), the levels of IL-6, IL-8, IL-13, MIP-
1a, TNF-a, and sICAM-1 in the eyes with mild and severe iris
damage were significantly higher than those in the eyes
without iris damage (P < 0.045). The levels of protein, IL-1b,
IL-17A, GM-CSF, IFN-a, IFN-c, and P-selectin in the eyes with
mild iris damage were significantly higher than that in the eyes
without iris damage (P < 0.04). The levels of IL-6 and MCP-1 in
eyes with severe iris damage were significantly higher than that
in the eyes without iris damage (P ¼ 0.0007 and P ¼ 0.0027,
respectively).
In pseudophakic eyes (Table 5, total 59 eyes), the IL-8 levels
in the eyes with mild and severe iris damage were significantly
FIGURE 2. Protein concentration in the AqH. The protein concentra-
tion in the AqH significantly increased to 0.98 6 0.14 mg/mL in eyes
with mild iris damage (P¼ 0.0033) and to 1.70 6 0.29 mg/mL in eyes
with severe iris damage, compared with eyes without iris damage (0.51
6 0.46 mg/mL). The protein concentration in the AqH significantly
correlated with the severity of iris damage (r ¼ 0.434, P < 0.001).
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higher than that in the eyes without iris damage (P ¼ 0.0001
and P¼ 0.0031, respectively). The levels of protein and sICAM-
1 in the eyes with severe iris damage were significantly higher
than that in the eyes without iris damage (P ¼ 0.03 and P ¼
0.034, respectively).
Aqueous Protein/Cytokine Levels and Iris Damage
Score (IDS)
Having demonstrated that the aqueous protein level was
correlated with the severity of iris damage, we sought to
evaluate the association of iris damage and aqueous levels of
protein and cytokines in detail. We assessed the aqueous
protein and cytokine levels after classifying the iris damage into
four grades as reported previously.12 In brief, IDS 0 indicates no
iris damage (Fig. 1A); IDS 1 is defined as iris damage limited
only to one quadrant (Fig. 1B); or no iris damage with laser
iridotomy (Fig. 1D); IDS 2 is defined as iris damage in two
quadrants (Fig. 1C); IDS 3 is defined as iris damage in three
quadrants (Fig. 1E); and IDS 4 is defined as iris damage in four
quadrants (Fig. 1F). The aqueous protein levels in the eyes with
IDS 0 increased from 0.52 6 0.05 mg/mL (Fig. 3) to 0.86 6
0.18 mg/mL in IDS1 (P > 0.99), 1.22 6 0.24 mg/mL in IDS2 (P
¼ 0.024), 1.62 6 0.30 mg/mL in IDS3 (P < 0.001), and 1.80 6
0.52 mg/mL in IDS4 (P < 0.001). The protein concentration in
the AqH significantly correlated with iris damage score (r ¼
0.469, P < 0.001). On the contrary, the aqueous cytokine
levels were more complex (Table 6; Fig. 4). Although the levels
of some aqueous cytokines were significantly elevated in eyes
with IDS 1 to 4 compared with those in eyes with IDS 0, there
were no statistically significant differences in aqueous cytokine
levels among eyes with IDS 1, 2, 3, and 4 (Fig. 4). However, IDS
was significantly positively correlated with the levels of IL-1a,
IL-1b, IL-4, IL-6, IL -8, IL -10, IL-12p70, IL-13, IL-17A, IFN-a, IFN-
c, MCP-1, TNF-a, E-selectin, P-selectin, sICAM-1, and IP-10
(Table 6; Spearman’s correlation, P < 0.028).
DISCUSSION
In the current study, we demonstrated that the iris damage was
associated with elevated cytokine levels in AqH. Furthermore,
TABLE 2. Aqueous Cytokine Levels in All Eyes
Aqueous
Cytokine No Iris Damage, N ¼ 126 Mild Iris Damage, N ¼ 51 Severe Iris Damage, N ¼ 24 P Value* P Value† P Value‡
IL-1a 62.9 6 7.2 (46.9) 102 6 19.5 (71.6) 97.6 6 17.7 (68.6) 0.012 0.55 0.0026
IL-1b 2.7 6 0.6 (1.1) 11.3 6 3.1 (3.1) 24.3 6 18.1 (1.6) 0.0001 0.46 0.0064
IL-4 26.3 6 2.6 (20.9) 48.1 6 5.9 (29.2) 40.36 5.4 (30.8) <0.0001 0.95 0.0001
IL-6 380 6 110 (9.4) 1497 6 466 (335) 1185 6 701 (210) <0.0001 0.50 <0.0001
IL-8 41.0 6 9.4 (16.6) 70.7 6 11.4 (39.5) 78.5 6 19.9 (51.9) <0.0001 0.77 <0.0001
IL-10 2.6 6 0.2 (1.8) 8.5 6 3.0 (3.7) 12.5 6 5.5 (4.1) <0.0001 0.57 <0.0001
IL–12p70 7.9 6 0.6 (6.5) 14.0 6 1.7 (8.5) 11.8 6 1.4 (9.0) 0.0001 0.95 0.001
IL-13 8.4 6 0.8 (7.2) 10.6 6 1.0 (9.6) 9.6 6 1.3 (9.2) <0.0001 0.41 0.11
IL-17A 5.6 6 0.4 (4.6) 10.6 6 2.0 (7.2) 8.3 6 1.0 (7.2) 0.0089 0.84 0.0073
MIP-1a 11–2 6 0.9 (9.2) 20.1 6 3.2 (12.3) 14.5 6 2.0 (11.8) 0.0081 0.67 0.07
MIP-1b 338 6 42.9 (303.7) 384 6 70.4 (323) 365 6 75.7 (294) 0.661 0.99 0.75
MCP-1 627 6 70.6 (466.7) 860 6 146 (615) 756 6 86.5 (694) 0.0036 0.57 0.0005
TNF-a 110 6 8.1 (80.9) 326 6 157 (102) 139 6 14.9 (122) 0.033 0.68 0.011
GM-CSF 5.4 6 1.1 (3.6) 8.0 6 1.9 (5.1) 8.8 6 2.8 (8.5) 0.16 0.52 0.068
IFN-a 4.5 6 0.4 (3.9) 6.5 6 0.8 (4.9) 4.1 6 0.4 (4.0) 0.0003 0.035 0.95
IFN-c 62.7 6 5.0 (51.9) 102.1 6 13.0 (66.6) 68.9 6 4.9 (62.6) <0.0001 0.26 0.95
E-Selectin 2739 6 236 (2295) 4326 6 732 (2812) 3863 6 512 (2783) 0.0004 0.83 0.002
P-Selectin 5477 6 432 (3895) 14147 6 2625 (7540) 10026 6 3409 (6850) <0.0001 0.21 0.004
sICAM-1 2093 6 235 (1313) 4721 6 737 (3100) 5279 6 1054 (3242) <0.0001 0.30 <0.0001
IP-10 377 6 160 (95.8) 302.9 6 56.8 (151) 400 6 115 (181.9) <0.0001 0.56 0.0013
Mean 6 SE (median) (pg/mL).
* Compared between eyes without iris damage and eyes with mild iris damage, Mann-Whitney U-test.
† Compared between eyes with mild iris damage and eyes with severe iris damage, Mann-Whitney U-test.
‡ Compared between eyes without iris damage and eyes with severe iris damage, Mann-Whitney U-test.
TABLE 3. Association Between Iris Damage Severity and Clinical Factors
Clinical Factors
Univariate Models* Multifactorial Model
q P Value
Model 1 Model 2
B P Value B P Value
Number of previous intraocular surgery 0.754 0.0001 0.336 0.0001 0.336 0.0001
IOL (þ¼1) 0.516 0.0001
Complicated Glaucoma (þ¼1) 0.491 0.0001 0.355 0.013 0.355 0.013
History of corneal transplantation (þ¼1) 0.371 0.0001
Axial length 0.170 0.018
DM (þ¼1) 0.032 0.66
Age 0.013 0.86
* Spearman’s correlation analysis.
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multivariate analysis showed that iris damage was correlated
with complicated glaucoma surgery and number of previous
intraocular surgeries. These results suggest that iris damage
lead to elevation in the levels of aqueous inflammatory
cytokines, which would be a useful clinical finding for
increased cytokine levels in AqH; however, there was no
significant difference in the aqueous cytokine levels between
mild and severe iris damage.
Corneal transplants are among the most successful solid
tissue transplants. The primary cause of graft failure is
endothelial decompensation, even in eyes without any
evidence of immunologic rejection.24 After corneal transplan-
TABLE 4. Aqueous Cytokine Levels in Phakic Eyes
Aqueous
Cytokine No Iris Damage, N ¼ 110 Mild Iris Damage, N ¼ 27 Severe Iris Damage, N ¼ 5 P Value* P Value† P Value‡
Protein 0.44 6 0.04 (0.33) 0.82 6 0.17 (0.61) 0.52 6 0.11 (0.31) 0.025 0.68 0.43
IL-1a 59.4 6 7.7 (45.9) 76.7 6 13.3 (63.9) 103 6 23.6 (82.6) 0.083 0.24 0.0007
IL-1b 2.7 6 0.6 (1.1) 9.7 6 4.3 (3.1) 56.3 6 54.1 (2.3) 0.0003 0.77 0.20
IL-4 25.4 6 2.8 (20.3) 42.1 6 5.8 (27.9) 42.9 6 14.9 (27.9) 0.0001 0.89 0.07
IL-6 223 6 86.2 (8.0) 969 6 291 (335) 3525 6 3310 (228) <0.0001 0.97 0.0024
IL-8 33.0 6 8.8 (16.2) 51.1 6 11.8 (34.8) 49.6 6 12.0 (38.8) 0.0001 0.58 0.0031
IL-10 2.4 6 0.2 (1.8) 4.5 6 0.6 (3.3) 4.1 6 0.7 (3.9) <0.0001 0.66 0.0019
IL–12p70 7.6 6 0.6 (6.4) 12.6 6 1.7 (8.5) 10.0 6 1.6 (10.8) 0.0013 0.96 0.046
IL-13 8.1 6 0.9 (6.9) 12.1 6 1.7 (9.5) 14.5 6 3.8 (13.6) <0.0001 0.52 0.012
IL-17A 5.6 6 0.5 (3.9) 12.9 6 3.6 (7.4) 9.9 6 3.8 (7.4) 0.0041 0.99 0.082
MIP-1a 11.1 6 1.0 (9.1) 18.0 6 2.7 (12.8) 16.6 6 3.9 (13.6) 0.0045 0.83 0.019
MIP-1b 332 6 47.5 (304) 345 6 65.9 (279) 424 6 154 (392) 0.82 0.56 0.30
MCP-1 590 6 77.3 (458) 634 6 64.3 (595) 662 6 72.5 (690) 0.058 0.84 0.0027
TNF-a 104 6 8.2 (61.4) 214 6 54.2 (74.1) 164 6 26.6 (154) 0.012 0.63 0.0073
GM-CSF 5.1 6 1.1 (3.6) 9.9 6 3.0 (5.1) 13.7§ 0.036
IFN-a 4.5 6 0.4 (3.9) 5.8 6 0.9 (5.0) 4.6 6 1.1 (6.5) 0.04 0.49 0.86
IFN-c 62.5 6 5.7 (52.0) 93.8 6 12.1 (68.8) 71.6 6 17.4 (56.8) <0.0001 0.31 0.27
E-Selectin 2728 6 264 (2268) 3424 6 475 (2677) 2783 6 771 (2404) 0.043 0.66 0.51
P-Selectin 5256 6 472 (3723) 10518 6 1786 (7540) 6907 6 1132 (8154) <0.0001 0.72 0.062
sICAM-1 1974 6 248 (1301) 3721 6 501 (2845) 3147 6 1000 (2278) <0.0001 0.68 0.045
IP-10 406 6 183 (94.1) 254 6 82 (129) 422 6166 (447) 0.015 0.39 0.16
Mean 6 SE (median), protein (mg/mL), cytokines (pg/mL).
* Compared between eyes without iris damage and eyes with mild iris damage, Mann-Whitney U-test.
† Compared between eyes with mild iris damage and eyes with severe iris damage, Mann-Whitney U-test.
‡ Compared between eyes without iris damage and eyes with severe iris damage, Mann-Whitney U-test.
§ Only one sample could be measured using multiplex beads assay among the samples in each group.
TABLE 5. Aqueous Cytokine Levels in Pseudophakic Eyes
Aqueous
Cytokine No Iris Damage, N ¼ 16 Mild Iris Damage, N ¼ 24 Severe Iris Damage, N ¼ 19 P Value* P Value† P Value‡
Protein 1.03 6 0.20 (1.0) 1.17 6 0.23 (1.1) 1.95 6 0.3 (1.7) 0.89 0.06 0.031
IL-1a 93.6 6 18.5 (71.4) 126 6 35.6 (72.4) 95.4 6 23.2 (64.4) 0.73 0.83 0.63
IL-1b 3.2 6 1.3 (1.3) 13.3 6 4.7 (3.3) 8.3 6 5.4 (1.6) 0.11 0.61 0.39
IL-4 33.7 6 4.5 (35.1) 54.9 6 10.7 (33.3) 39.6 6 5.9 (31.8) 0.39 0.78 0.78
IL-6 1461 6 613 (87.4) 2092 6 931 (280) 570 6 227 (191) 0.47 0.41 0.98
IL-8 33.0 6 8.8 (16.2) 51.1 6 11.8 (34.8) 49.6 6 12.0 (38.8) 0.0001 0.58 0.0031
IL-10 3.5 6 0.5 (3.3) 13.3 6 6.4 (3.8) 14.7 6 6.97 (4.4) 0.52 0.95 0.16
IL–12p70 10.5 6 1.5 (7.9) 15.6 6 3.2 (8.5) 12.3 6 1.8 (8.9) 0.52 0.95 0.55
IL-13 10.7 6 1.3 (9.2) 9.2 6 1–2 (9.9) 8.1 6 1.1 (8.1) 0.94 0.34 0.16
IL-17A 7.8 6 1.1 (7.1) 8.6 6 2.0 (7.2) 7.9 6 1.0 (7.2) 0.74 0.71 0.94
MIP-1a 12.5 6 1.4 (12.9) 22.4 6 6.1 (11–2) 13.8 6 2.4 (11.3) 0.98 0.68 0.90
MIP-1b 414 6 79.4 (362) 426 6 129 (348) 349 6 88.3 (261) 0.50 0.90 0.31
MCP-1 902 6 162 (670) 1115 6 296 (617) 805 6 107 (697) 0.98 0.94 0.88
TNF-a 158 6 28.6 (122) 130.9 6 25.6 (99.7) 128 6 17.7 (109) 0.24 0.52 0.49
GM-CSF 13.2 6 3.9 (13.2) 5.9 6 2.1 (3.6) 6.3 6 2.2 (6.3) 0.16 0.56 0.88
IFN-a 4.4 6 0.7 (3.6) 7.3 6 1.3 (4.8) 3.9 6 0.4 (4.0) 0.021 0.02 0.99
IFN-c 65 6 7.0 (50.9) 112 6 24.3.1 (64.3) 68.2 6 4.6 (68.3) 0.12 0.44 0.53
E-Selectin 2821 6 395 (2404) 5304 6 1425 (3018) 4147 6 606 (2840) 0.12 0.99 0.11
P-Selectin 6959 6 1038 (5105) 18230 6 5139 (8395) 10847 6 4301 (6161) 0.13 0.18 0.86
sICAM-1 3081 6 726 (2201) 5846 6 1445 (3151) 5840 6 1285 (3390) 0.039 0.32 0.034
IP-10 179 6 52 (117) 358 6 77 (191) 394 6 141 (169) 0.02 0.57 0.14
Mean 6 SE (median), protein (mg/mL), cytokines (pg/mL).
* Compared between eyes without iris damage and eyes with mild iris damage, Mann-Whitney U-test.
† Compared between eyes with mild iris damage and eyes with severe iris damage, Mann-Whitney U-test.
‡ Compared between eyes without iris damage and eyes with severe iris damage, Mann-Whitney U-test.
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tation, the ECD reduces in a chronic fashion over years,25 and
rates of ECD reduction are exacerbated from 2.6% to 9.7%
annually.26–29 The risk factors for postoperative endothelial cell
loss after corneal transplantation include donor age, recipient
age, graft diameter, lens status, glaucoma, graft rejection,
bullous keratopathy (compared with FECD), and peripheral
corneal diseases.25,30–34 However, the exact mechanism of
chronic ECD loss is still poorly understood. Previous laboratory
studies have shown that inflammatory cytokines induce
apoptosis in corneal endothelial cells.17,35,36 We recently
reported that severe preexisting iris damage was a risk factor
for graft failure and rapid ECD loss after DSAEK.12 Further-
more, we found that the inflammatory cytokine levels in AqH
increased in eyes with BK and reduced ECD.13 We postulate
that the results of the elevated proinflammatory cytokine levels
may represent ‘‘chronic pathological inflammation,’’ which
might induce the elevation of IL-10, an anti-inflammatory
cytokine, due to the negative feedback mechanism.37,38
Chronic inflammation may induce endothelial cell loss over
time after intraocular surgeries or affect the graft survival after
corneal transplantation, especially in eyes with iris damage. It
would be valuable to study the correlation analyses between
preoperative aqueous cytokines and the decrease in ECD over
time after corneal transplantation, to assess the influence of
elevated levels of cytokines on the endothelial cell loss and for
identifying the cytokines that determine the fate of endothelial
cell survival after corneal transplantation.
Multifactorial regression analyses identified that the iris
damage severity significantly correlated with the presence of
complicated glaucoma and number of previous intraocular
surgeries. Regarding the impact of complicated glaucoma on
the aqueous cytokine levels, the current study included 23
eyes with complicated glaucoma (12 eyes after trabeculectomy
for the treatment of primary open angle glaucoma [POAG], 8
eyes with secondary glaucoma after complicated intraocular
surgeries, and 3 eyes with congenital glaucoma after multiple
glaucoma surgeries). We expected higher levels of AqH
cytokines in the eyes with histories of complicated glaucoma,
because glaucoma surgery has been reported as a factor for
reduced ECD after corneal transplantation.25,31,33 Among the
cytokines, the levels of the following cytokines were high
especially in the eyes with severe iris damage (N ¼ 12): IL-1a
(108 6 29.6 pg/mL), IL-6 (799 6 344 pg/mL), MCP-1 (942 6
154 pg/mL), IFN-c (72.4 6 6.5 pg/mL), and TNF-a (166 6 27.1
pg/mL). In contrast, all the four eyes with POAG, which had
normal IOPs at the time of AqH collection, had no iris damage
and had normal AqH cytokine levels (IL-1a: 48.9 6 4.3 pg/mL,
IL-6: 16.0 6 6.8 pg/mL, MCP-1: 648 6 80 pg/mL, IFN-c: 56.9 6
2.4 pg/mL, and TNF-a: 77.1 6 5.3 pg/mL).13 Although we had
to increase the number of eyes with complicated glaucoma and
uncomplicated POAG for statistical analyses, the results suggest
that the presence of complicated glaucoma leads to elevated
levels of aqueous cytokines as reported previously.13,39
Furthermore, the study showed that the levels of aqueous
protein and cytokine were elevated in the eyes with iris
damage both in phakic and pseudophakic conditions. In
phakic eyes, the causes of iris damage were LI and surgical
iris damage during corneal transplantation and trabeculectomy,
whereas the phakic eyes without iris damage included cataract
eyes and eyes with FECD. We previously reported the elevation
of aqueous cytokines in eyes with a history of LI and past
intraocular surgeries.13 To assess the association between iris
damage and the cytokine levels in eyes after corneal
transplantation, we compared the levels of aqueous cytokines
among the different iris damage severity after selecting the
eyes after corneal transplantation (Supplementary Table S1, 19
eyes after PKP, 6 eyes after DSAEK, and 2 eyes after anterior
lamellar keratoplasty). The intraocular surgeries that caused
the iris damage were performed 6 months to 10 years before
the AqH collection. Although we have to evaluate the
association among the kind of surgeries and the interval
between surgeries and AqH collection after increasing the
number of subjects, we postulated that iris damage during
complicated intraocular surgery might induce the elevated
levels of aqueous cytokines over the years in a chronic fashion.
The previous laboratory studies showed that the interaction
among iris pigment epithelial cells (I-CB cells in the literature),
and the components of the AqH might maintain the
homeostasis of the immune system in the anterior chamber.
The previous reports on the immunosuppressive effects of the
iris pigment epithelium are shown in Table 7.8,9,12,40–48
Streilein et al.7 reported that the iris pigment epithelial cells
have immunomodulatory properties. The elevated cytokine
levels might be attributed to the breakdown of the BAB
because the aqueous protein level correlated significantly with
the iris damage severity (r¼0.434, P < 0.001). It is tempting to
speculate that the results of this study suggest that the lack of
immunomodulatory factors from the I-CB cells can change the
microenvironment in the AqH, such as elevation in the levels of
aqueous inflammatory cytokines, considering the results of
previous laboratory reports. In general, cytokines are produced
FIGURE 3. Protein level in AqH stratified based on iris damage score.
Aqueous protein level increased with iris damage score.
TABLE 6. Correlation Between Aqueous Cytokine Levels and Iris
Damage Score
Aqueous Cytokine Correlation Coefficient P Value
IL-1a 0.276 0.0002
IL-1b 0.272 0.0004
IL-4 0.392 <0.0001
IL-6 0.490 <0.0001
IL-8 0.459 <0.0001
IL-10 0.457 <0.0001
IL-12p70 0.316 <0.0001
IL-13 0.278 0.0006
IL-17A 0.294 0.0002
MIP-1a 0.161 0.055
MIP-1b 0.028 0.695
MCP-1 0.293 <0.0001
TNF-a 0.279 0.0007
GM-CSF 0.206 0.08
IFN-a 0.174 0.028
IFN-c 0.305 <0.0001
E-Selectin 0.289 <0.0001
P-Selectin 0.352 <0.0001
sICAM-1 0.454 <0.0001
IP-10 0.343 <0.0001
Spearman’s correlation analysis.
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FIGURE 4. Cytokine levels in aqueous humor stratified based on iris damage score. Levels of some cytokines were higher in the eyes with IDS 1-4
compared with the eyes with IDS 0.
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in immune cells in response to specific stimuli, such as
infection, trauma, or autoimmune diseases. Hence, further
evaluation of the causes of chronic inflammation in the
anterior chamber is needed in future studies.
Because cytokines are very sensitive, some systemic
condition can affect the aqueous cytokine levels, as reported
for the elevation of tear cytokine levels with deterioration of
rheumatoid arthritis.49 Systemic inflammatory conditions can
also affect AqH cytokine levels via elevation of serum cytokines
or breakdown of the BAB. We thoroughly checked the clinical
records of all patients regarding steroid use and systemic
diseases. There were nine patients with systemic inflammatory
diseases: three patients with rheumatoid arthritis, two patients
with asthma, one patient with atopic dermatitis, one patient
with polymyositis, one patient with polyneuritis, and one
patient with Sjogren syndrome (2 patients without iris damage,
3 patients with mild iris damage, and 4 patients with severe iris
damage). We compared the aqueous protein and cytokine
levels between these nine patients and 192 patients without
systemic diseases and found that there were no statistically
significant differences in the aqueous protein and cytokine
levels, except IL-8 (39.7 6 32.0 pg/mL in the 9 patients with
systemic inflammatory diseases and 54.0 6 102pg/mL in the
192 patients without systemic inflammatory diseases). Topical
steroids can also potentially be used as a treatment modality to
suppress AqH cytokine levels. Regarding steroid use, topical
steroids were administered in the eyes after corneal transplan-
tation (10 eyes), pseudophakic bullous keratopathy (PBK; eight
eyes), and trabeculectomy (three eyes), when the AqH samples
were collected. No patients received systemically administered
steroids. We analyzed the differences in protein and cytokine
levels between the eyes administered with topical steroids and
the eyes that did not receive such treatment. However, we did
not find any clinically relevant difference.
This study has some limitations. Firstly, this study included
only patients who had undergone corneal transplantation and
cataract surgery, and did not include patients with retinal or
glaucoma diseases with normal ECD. All the eyes that
underwent multiple complicated intraocular surgeries had
severe iris damage and this study did not include eyes with a
healthy iris, which underwent several intraocular surgeries.
Such heterogenous selection of subjects can induce selection
bias. In such eyes, the elevation in the levels of aqueous
cytokines has been reported and we have to consider other
reasons for the elevated levels of aqueous cytokines.15,16,50,51
We will have to conduct comprehensive studies to evaluate the
effect of different kinds of surgeries on aqueous cytokines in
the future. Second, whereas the aqueous proteins level was
directly correlated with the severity of iris damage (Figs. 3),
there were no statistically significant differences in aqueous
cytokine levels between the eyes with mild and severe iris
damage (Supplementary Fig. S1). Iris damage was associated
with various clinical factors and the measurement of cytokines
is very sensitive, which might make the results of cytokine
levels more complex in the context of iris damage. Thus, we
will conduct proteomics analysis of AqH to find the essential
molecular mechanism for the results in a comprehensive way.
Thirdly, we included only Japanese eyes with brown pigment-
ed iris. In Asian eyes, iris damage is easy to identify, compared
with in eyes with less pigmentation as in the iris of Caucasian
eyes. We need further studies to evaluate the effect of iris
damage on the levels of aqueous cytokines in other races.
Forth, the interval between the previous glaucoma surgery and
AqH collection can affect the aqueous levels of cytokines. The
mean interval was 14.4 6 14.8 years, ranging from 2 to 54
years (total 15 eyes: 12 eyes after trabeculectomy and 3 eyes
with multiple glaucoma surgeries). The aqueous levels of
protein and cytokines were not significantly correlated with
the interval between the glaucoma surgery and AqH collection,
although we have to increase the number of subjects after
glaucoma surgery. The other limitation is that we could not
TABLE 7. Literature Review on the Association Between Iris Pigment Epithelium and Anterior Chamber Inflammation
Author (y)
Cell Line/
Animal/
Human
Model/
Subjects Molecules
Principal
Source
Principal Cellular Targets
and Biologic Effects
Streilein, et al. (1990)8 Cell line MLR TGF-b AqH T cell; suppress proliferation
Streilein, et al. (1991)9 Cell line MLR NA I-CB T cell; suppress proliferation
Suzuma, et al. (1997)40 Rat EIU P-selectin I-CB Immune cells; increased cell infiltration in the iris
and aqueous protein levels
Suzuma, et al. (1998)41 Rat EIU E-selectin I-CB, retina Immune cells; increased cell infiltration in the iris
and aqueous protein levels
Marie, et al. (1999)42 Rat EIU TNF-a, IL-6,
IL-13
I-CB Immune cells; IL-13 suppresses cell infiltrates in the
iris by downregulating TNF-a and IL-6
Yoshida, et al. (2000)43 Cell line/
mouse
MLR/ACAID TGF-b I-CB/AqH T cell; suppress proliferation
Downregulate IFN-c, IL-2, IL-4 and IL-10
Ohta, et al. (2000)44 Mouse EIU/MLR TGF-b T cell; suppress proliferation
Yoshida, et al. (2000)45 Cell line/
mouse
MLR CD95 I-CB T cell; suppress proliferation
Downregulate IFN-c, IL-2, IL-4.
Lemaitre, et al. (2001)46 Mouse EIU IL-13 Exogenous IL-13 Exogenous IL-13 suppresses cell infiltrates in the
iris by downregulating MCP-1 and MIP
Mo, et al. (2003)47 Mouse PDS/ACAID CD95 I-CB I-CB contribute to ACAID and suppress T cell
proliferation
Sugita, et al. (2007)48 Cell line Treg assay B7 I-CB I-CB induce Treg
Ishii, et al. (2016)12 Human EK NE NE Iris damage was associated with endothelial cell
loss, leading to graft failure
The current study Human Cataracts/corneal
disease
Cytokine NE Iris damage was associated with elevated cytokine
levels in AqH
MLR, mixed lymphocyte reactio; NA, not available; EIU, endotoxin-induced uveitis; ACAID, anterior chamber associated immune deviation; PDS,
pigment dispersion syndrome; Treg, regulatory T cell; EK, endothelial keratoplasty; NE, not evaluated; BK, bullous keratopathy.
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grade flare in the AqH owing to the presence of corneal
opacities in some of the subjects.
In conclusion, we have shown that the iris damage is
associated with elevated levels of aqueous protein as well as
inflammatory cytokines, such as IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-
10, IL-13, IL-17A, MCP-1, TNF-a, E-selectin, P-selectin, MIP-1a
and sICAM-1. The multivariate analyses revealed that the iris
damage severity is associated with the number of previous
intraocular surgeries and with the presence of complicated
glaucoma. Thus, the preexisting iris damage can be one of the
useful clinical parameters for chronic breakdown of BAB and
elevated inflammatory cytokines, although there was no direct
correlation between the extent of iris damage and the level of
cytokines.
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